artemis logo

Artemis Funds (Lux) – UK Select
Q4 2025 update

Published on 22 Jan 2026

Source for all information: Artemis as at 31 December 2025, unless otherwise stated.

Objective 

The fund is actively managed. Its aim is to increase the value of shareholders’ investments primarily through capital growth.

Review of the quarter to 31 December 2025 

Despite the best efforts of the government, 2025 proved to be a good year for UK equities, both in absolute terms and relative to the performance of global indices. A weaker dollar combined with a desire from investors to diversify their exposure away from the Magnificent Seven provided a backdrop for other markets to re-rate. Strong earnings momentum from many of the FTSE’s largest companies and a low absolute starting valuation allowed the UK to fully participate in the trend. At an index level, the two notable themes were the ongoing rotation from growth to value as well as the concentration of returns from the 10 largest stocks. 

Our strategy's focus on free cashflow allowed it to benefit from the growth-to-value rotation, while our overweight positions in financials and aerospace-related holdings and underweights in staples and AI ‘winners’ enabled it to outperform in a very narrow market.

Artemis Funds (Lux) UK Select made 5.1% during the three-month period, compared with 6.4% from its FTSE All-Share benchmark and 2.5% from its UK Flex-Cap Equity sector average. 


Three monthsSix monthsOne yearThree yearsFive years
Artemis Funds (Lux) – UK Select5.1%11.3%28.4%n/an/a
FTSE All-Share index6.4%13.7%24.0%n/an/a
UK Flex-Cap Equity average 2.5%5.3%11.5%n/an/a

Past performance is not a guide to the future. Source: Artemis/Lipper Limited, class I accumulation GBP to 31 December 2025. All figures show total returns with dividends and/or income reinvested, net of all charges. Performance does not take account of any costs incurred when investors buy or sell the fund. Returns may vary as a result of currency fluctuations if the investor’s currency is different to that of the class.

Detractors 

3i reacted negatively to weaker like-for-like trading at Action in October and early November. This was driven entirely by the French stores (which account for just under one-third of sales), due to a combination of weak consumer sentiment (political uncertainty), unseasonably warm weather and greater discounting from one of its peers which has collapsed into administration. The other two-thirds of the business continues to trade well. Having halved our position over the past 18 months on valuation concerns, we have reversed direction and added to our holding as we believe the compelling store economics and significant long-term roll-out potential remain unchanged.  

Marks & Spencer had a volatile year as investors proved reluctant to look past the cyberattack. We added to our holding throughout 2025 and remain enthused that the shares will catch up much of the relative ground they lost. 

Our holdings in bookmakers Flutter and Evoke were hit by higher-than-expected tax rises in the Budget. On the back of this we expect the UK market to shrink and consolidate, allowing the larger operators to gain market share gains, but ultimately it is a negative for the industry profit pool.

Whitbread was another Budget loser as a substantial change in rateable values of its UK hotel portfolio will see its business rates bill double from its current level of about £150m per annum over the next three years. This is a material headwind on a business that makes about £600m of operating profit per annum. The rateable values can be appealed when they kick in in April and we expect Whitbread and the rest of the hotel industry to push back, leading to a much smaller increase in the total bill. Until there is more clarity, the shares are likely to remain in the doldrums and for this reason we have not added to our holding.

Pharmaceuticals AstraZeneca and GSK, which we don't own, outperformed as the market reacted positively to a deal signed on drug pricing for Medicaid and direct-to-consumer sales in the US.

Contributors 

Banks Standard Chartered, Barclays, NatWest and Lloyds delivered strong gains, especially towards the end of the period as fears that the Budget could lead to a meltdown in the gilt market and expected windfall taxes failed to materialise. These factors, together with the Bank of England's decision to reduce capital requirements, helped them to close some of the valuation gap with Asian and European peers.  

Ryanair announced better-than-expected results and encouraging comments on forward bookings. Exposure to eastern Europe also leaves it as one of the few liquid names that could benefit from a Ukraine/Russia ceasefire.

From a relative point of view, we benefited from avoiding RELX, BAE Systems and Experian.

Activity 

We took profits from Standard Chartered and Barclays to control position sizes following further strong performance. We remain enthusiastic about the outlook for both. We invested the proceeds into 3i, Marks & Spencer and Smurfit Westrock where we remain confident in their medium-term prospects despite recent weakness.

Fund 10-year discrete performance


2025202420232022202120202019201820172016
Artemis Funds (Lux) – UK Select28.4%n/an/an/an/an/an/an/an/an/a
FTSE All-Share24.0%n/an/an/an/an/an/an/an/an/a

Past performance is not a guide to the future. Source: Artemis/Lipper Limited, class I accumulation GBP to 31 December 2025. All figures show total returns with dividends and/or income reinvested, net of all charges. Performance does not take account of any costs incurred when investors buy or sell the fund. Returns may vary as a result of currency fluctuations if the investor’s currency is different to that of the class.

Outlook 

For the first time since Covid, we are no longer more optimistic on the outlook for UK consumer spending than consensus. Modest fiscal tightening combined with little real income growth will leave this measure dependent on a decline in the (elevated) savings rate. This, we feel, is likely, particularly if lower inflation allows the Bank of England to cut interest rates faster. We are not bearish, but instead find ourselves in agreement with the consensus growth forecasts for the UK economy. Politics looks unlikely to fade into the background and we can see the potential for another period of elevated uncertainty should there be a challenge to the prime minister post the local elections in May. 

Globally, loose fiscal and monetary policy should be supportive for economic growth and markets. Under Donald Trump's presidency, geopolitics is never a straightforward call and there will be many potential changes to the global order in the year ahead. While these are difficult to predict, Trump does pay attention to markets and opinion polls, which is worth remembering if either one has a severe reaction to any of his policy decisions.

This year is likely to be one where multiple expansion is harder to come by, meaning the bulk of returns will come from earnings growth and income. Against this backdrop we believe that our portfolio companies are well placed to perform: we continue to find an above-average number of stock-specific insights and so are hopeful that the fund's earnings growth can exceed consensus forecasts. Combining net earnings growth, yield and starting valuations, we see scope for another year of attractive real returns in 2026. We would however caution that after three consecutive years in which returns have averaged about 25% per annum and given the current less extreme valuation dispersion within the market, it feels sensible to expect more modest gains.

FOR PROFESSIONAL INVESTORS AND/OR QUALIFIED INVESTORS AND/OR FINANCIAL INTERMEDIARIES ONLY. NOT FOR USE WITH OR BY PRIVATE INVESTORS.

CAPITAL AT RISK. All financial investments involve taking risk and the value of your investment may go down as well as up. This means your investment is not guaranteed and you may not get back as much as you put in. Any income from the investment is also likely to vary and cannot be guaranteed.

This is a marketing communication. Before making any final investment decisions, and to understand the investment risks involved, refer to the fund prospectus (or in the case of investment trusts, Investor Disclosure Document and Articles of Association), available in English, and KIID/KID, available in English and in your local language depending on local country registration, available in the literature library.

Fund commentary history

Fund commentary history

2026
2024
See all fund commentaries

Risks specific to Artemis Funds (Lux) – UK Select

  • Market volatility risk The value of the fund and any income from it can fall or rise because of movements in stockmarkets, currencies and interest rates, each of which can move irrationally and be affected unpredictably by diverse factors, including political and economic events.
  • Currency risk The fund’s assets may be priced in currencies other than the fund base currency. Changes in currency exchange rates can therefore affect the fund's value.
  • Derivatives risk The fund may invest in derivatives with the aim of profiting from falling (‘shorting’) as well as rising prices. Should the asset’s value vary in an unexpected way, the fund value could reduce.
  • Leverage risk The fund may operate with a significant amount of leverage. Leverage occurs when the economic exposure created by the use of derivatives is greater than the amount invested. A leveraged portfolio may result in large fluctuations in its value and therefore entails a high degree of risk including the risk that losses may be substantial.
  • Charges from capital risk Where charges are taken wholly or partly out of a fund's capital, distributable income may be increased at the expense of capital, which may constrain or erode capital growth.

Important information

The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.